MedTrace Logo

Effect of a Lactobacillus Strain on the Prevention of Recurrent Vaginal Candidiasis

NCT04639544 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2021-01-22

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy of the consumption of the one probiotic strain in the prevention of new vaginal candidiasis events in women with recurrent vaginal candidiasis. This is a preliminary study whose purpose is to know if this probiotic is effective in reducing the number of candidiasis events and / or increasing the time between possible relapses in women diagnosed with RVVC.

Conditions

  • Recurrent Vulvovaginal Candidiasis

Interventions

DIETARY_SUPPLEMENT

Placebo

Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits

DIETARY_SUPPLEMENT

Lactobacillus strain

Each participant will consume 1 capsule per day in one of the main meals without any restriction in the diet or in their life habits

Sponsors & Collaborators

  • Biosearch S.A.

    lead INDUSTRY

Principal Investigators

  • Jose Maldonado Lobón, PhD · Biosearch S.A.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2021-08-31
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04639544 on ClinicalTrials.gov